United States

Back to map

Showing 261-270 of 334 grants

Title Institution Researcher Program Duration Total Award Amount
Localized immune modulation to enable long-term beta cell survival William Marsh Rice University Omid Veiseh Cures 01-September-2022 to 31-August-2025 $600.000,00
A Phase 2 Study Evaluating Short-Term Efficacy of Tonabersat (Xiflam) for Diabetic Macular Edema Jaeb Center for Health Research Adam Glassman Improving Lives 01-September-2022 to 01-January-2026 $273.424,00
Real time monitoring of a cell therapy product to assess and modify transplant health post-engraftment in patients with type 1 diabetes Minutia Katy Digovich Cures 01-November-2022 to 30-November-2025 $1.198.600,00
Discovering early diagnostic markers of cardiovascular disease risk with lipidomics in a 30-year longitudinal prospective type 1 diabetes cohort University of Wisconsin-Madison (Board of Regents University of Wisconsin System) Judith Simcox Improving Lives 01-November-2022 to 31-October-2025 $799.988,63
Development of a new nanotechnology for immune-tolerizing therapy against T1D EVOQ Therapeutics, Inc. Vishalakshi Krishnan Cures 01-September-2022 to 28-February-2026 $1.110.000,00
Assessment of Beta Cell Small Extracellular Vesicles in the Pathogenesis of Type 1 Diabetes Mayo Clinic Naureen Javeed Cures 01-September-2022 to 31-August-2025 $400.000,00
Using genetics to better diagnose and treat adult-onset T1D in multi-ethnic US population Geisinger Clinic David Carey Cures 01-November-2022 to 30-September-2026 $1.469.640,10
Bioactive Granular Hydrogels for Islet Delivery Regents of the University of Michigan Maria Coronel Cures 01-September-2022 to 31-August-2025 $400.000,00
A Multi-task Learning Framework for Developing Genetic Risk Score (GRS) Models of T1D for Multi-Ethnic Population University of Washington Shuai Huang Cures 01-August-2022 to 31-August-2025 $300.081,37
Improving prediction of T1D risk by establishing a self-administered CGM-based technology and whole genome-based polygenic risk scores in diverse populations Rector & Visitors of the University of Virginia Leon Farhy Cures 01-August-2022 to 31-July-2025 $599.999,66